Table 3 Correlation between AURKA intensity and clinical features based on GSE136755
Parameter | Characteristic | No. patients (%) | AURKA intensity | Statistics | P value |
|---|---|---|---|---|---|
Gender | Female | 26 (40.0) | 6.19 ± 0.97 | t = − 1.458 | 0.150 |
Male | 39 (60.0) | 6.63 ± 1.47 |  |  | |
Age | < 68 | 31 (47.7) | 6.28 ± 1.17 | t = 1.022 | 0.311 |
≥ 68 | 34 (52.3) | 6.62 ± 1.41 |  |  | |
Location* | Stomach | 43 (66.2) | 6.14 ± 1.25 |  F = 4.306 | 0.018 |
Non-stomach | 16 (24.6) | 6.95 ± 0.99 |  |  | |
Metastasis | 6 (9.2) | 7.39 ± 1.74 |  |  | |
Risk* | High | 17 (26.2) | 7.54 ± 1.30 |  F = 11.898 | < 0.001 |
Intermediate | 9 (13.8) | 5.75 ± 0.54 |  |  | |
Low | 22 (33.8) | 6.06 ± 0.94 |  |  | |
Very low | 11 (16.9) | 5.66 ± 0.74 |  |  | |
Stage* | IV | 9 (13.8) | 7.94 ± 1.63 |  F = 10.686 | < 0.001 |
III | 9 (13.8) | 6.85 ± 0.89 |  |  | |
II | 8 (12.3) | 7.13 ± 1.55 |  |  | |
I | 39 (60.0) | 5.89 ± 0.84 |  |  | |
Mutation | Sensitive | 56 (86.2) | 6.39 ± 1.21 |  F = 2.541 | 0.087 |
Resistance | 7 (10.8) | 7.33 ± 1.84 |  |  | |
 N/A | 2 (3.1) | 5.29 ± 0.20 |  |  | |
Mutation | Sensitive | 56 (88.9) | 6.39 ± 1.21 | t = 1.814 | 0.075 |
Resistance | 7 (11.1) | 7.33 ± 1.84 |  |  |